Plasma pTau‐217 and N‐terminal tau (NTA) enhance sensitivity to identify tau PET positivity in amyloid‐β positive individuals

Predicting amyloid PET and tau PET stages with plasma biomarkers

(2023) Clifford R Jack et al.   BRAIN

Blood phospho-tau in Alzheimer disease: analysis, interpretation, and clinical utility

(2022) Thomas K. Karikari et al.   Nature Reviews Neurology

Early-stage Alzheimer disease: getting trial-ready

(2022) Paul S. Aisen et al.   Nature Reviews Neurology

Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer’s disease

(2022) Shorena Janelidze et al.   BRAIN

Association of Donanemab Treatment With Exploratory Plasma Biomarkers in Early Symptomatic Alzheimer Disease

(2022) Michael J. Pontecorvo et al.   JAMA Neurology

Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline

(2022) Rik Ossenkoppele et al.   NATURE MEDICINE

Lecanemab in Early Alzheimer’s Disease

(2022) Christopher H. van Dyck et al.   NEW ENGLAND JOURNAL OF MEDICINE

Association of Phosphorylated Tau Biomarkers With Amyloid Positron Emission Tomography vs Tau Positron Emission Tomography

(2022) Joseph Therriault et al.   JAMA Neurology

Donanemab in Early Alzheimer’s Disease

(2021) Mark A. Mintun et al.   NEW ENGLAND JOURNAL OF MEDICINE

Alzheimer disease

(2021) David S. Knopman et al.   Nature Reviews Disease Primers

N-terminal and mid-region tau fragments as fluid biomarkers in neurological diseases

(2021) Anniina Snellman et al.   BRAIN

Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts

(2020) Thomas K Karikari et al.   LANCET NEUROLOGY

18F-MK-6240 PET for early and late detection of neurofibrillary tangles

(2020) Tharick A Pascoal et al.   BRAIN

Determining Amyloid-β positivity using [18F]AZD4694 PET imaging

(2020) Joseph Therriault et al.   JOURNAL OF NUCLEAR MEDICINE

ATN classification and clinical progression in subjective cognitive decline

(2020) Jarith L. Ebenau et al.   NEUROLOGY

Time course of phosphorylated-tau181 in blood across the Alzheimer’s disease spectrum

(2020) Alexis Moscoso et al.   BRAIN

Frequency of biologically-defined AD in relation to age, sex, APOEε4 and cognitive impairment

(2020) Joseph Therriault et al.   NEUROLOGY

Associations of Plasma Phospho-Tau217 Levels With Tau Positron Emission Tomography in Early Alzheimer Disease

(2020) Shorena Janelidze et al.   JAMA Neurology

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease

(2018) Clifford R. Jack et al.   Alzheimers & Dementia

Longitudinal tau PET in ageing and Alzheimer’s disease

(2018) Clifford R Jack et al.   BRAIN

In vivo quantification of neurofibrillary tangles with [18F]MK-6240

(2018) Tharick A. Pascoal et al.   Alzheimers Research & Therapy

Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic

(2018) Harald Hampel et al.   Nature Reviews Neurology

On the path to 2025: understanding the Alzheimer’s disease continuum

(2017) Paul S. Aisen et al.   Alzheimers Research & Therapy

Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial

(2016) Serge Gauthier et al.   LANCET

A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers

(2016) Clifford R. Jack et al.   NEUROLOGY

pROC: an open-source package for R and S+ to analyze and compare ROC curves

(2011) Xavier Robin et al.   BMC BIOINFORMATICS

The use of PET in Alzheimer disease

(2010) Agneta Nordberg et al.   Nature Reviews Neurology

A probabilistic MR atlas of the human cerebellum

(2009) Jörn Diedrichsen et al.   NEUROIMAGE